Shares of Cullman Bancorp, Inc. (NASDAQ:CULL – Get Rating) traded down 0.6% during trading on Tuesday . The company traded as low as $10.83 and last traded at $10.83. 545 shares were traded during mid-day trading, a decline of 82% from the average session volume of 3,101 shares. The stock had previously closed at $10.90.
Cullman Bancorp Stock Performance
The stock's 50 day moving average price is $11.65 and its 200 day moving average price is $11.33. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.15. The firm has a market cap of $80.25 million, a PE ratio of 20.43 and a beta of 0.11.
Get Cullman Bancorp alerts:Cullman Bancorp Dividend Announcement
The company also recently declared an annual dividend, which was paid on Wednesday, February 22nd. Investors of record on Wednesday, February 1st were paid a dividend of $0.12 per share. This represents a yield of 0.98%. The ex-dividend date was Tuesday, January 31st. Cullman Bancorp's dividend payout ratio (DPR) is 22.64%.
Institutional Investors Weigh In On Cullman Bancorp
A hedge fund recently raised its stake in Cullman Bancorp stock. Alliancebernstein L.P. increased its position in shares of Cullman Bancorp, Inc. (NASDAQ:CULL – Get Rating) by 14.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 367,217 shares of the company's stock after buying an additional 45,555 shares during the period. Alliancebernstein L.P. owned about 4.96% of Cullman Bancorp worth $4,219,000 at the end of the most recent reporting period. Institutional investors own 7.00% of the company's stock.
About Cullman Bancorp
(Get Rating)
Cullman Bancorp, Inc is a holding company that engages in the provision of financial savings services through its subsidiary. Its subsidiary business offers deposits and loans. The company was founded in 1887 and is headquartered in Cullman, AL.
Featured Articles
- Get a free copy of the StockNews.com research report on Cullman Bancorp (CULL)
- After an Earnings Blowout, Is Ciena Stock a Buying Opportunity?
- Here's Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
- Meta Breaks Out Of A Base, Looks Like A Growth Stock Again
- The Bottom Is In For McCormick & Company
- Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Receive News & Ratings for Cullman Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullman Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.